Biobanking for characterization of pediatric malignancies.
Recruiting
- Conditions
- All patients suspected of, diagnosed with and/or treated for, or in follow-up for a pediatric malignancy at the Princess Maxima Center for pediatric oncology.
- Registration Number
- NL-OMON21619
- Lead Sponsor
- Prinses Maxima Centrum voor kinderoncologie
- Brief Summary
ot applicable
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 2750
Inclusion Criteria
Diagnosis and/or treatment in the Princess Maxima Center.
-Written informed consent according to (inter)national law and regulations
Exclusion Criteria
-Patients for whom the physicians or investigators considers that participation in this study is either not appropriate or poses unacceptable risks for the patient (e.g. when collection of additional material poses too many risks or potential harm).
Study & Design
- Study Type
- Not specified
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Establish a biobank of patient material for future biomedical research. As such there is no formal endpoint or statistical consideration regarding the size of the biobank.
- Secondary Outcome Measures
Name Time Method